Lexaria Bioscience (LEXX) Other Gross PP&E Adjustments (2017 - 2025)
Historic Other Gross PP&E Adjustments for Lexaria Bioscience (LEXX) over the last 11 years, with Q4 2025 value amounting to $697487.0.
- Lexaria Bioscience's Other Gross PP&E Adjustments rose 64480.53% to $697487.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $697487.0, marking a year-over-year increase of 64480.53%. This contributed to the annual value of $665510.0 for FY2025, which is 1195.05% up from last year.
- Lexaria Bioscience's Other Gross PP&E Adjustments amounted to $697487.0 in Q4 2025, which was up 64480.53% from $665510.0 recorded in Q3 2025.
- Lexaria Bioscience's 5-year Other Gross PP&E Adjustments high stood at $697487.0 for Q4 2025, and its period low was -$737903.0 during Q4 2022.
- Over the past 5 years, Lexaria Bioscience's median Other Gross PP&E Adjustments value was -$104781.0 (recorded in 2021), while the average stood at -$16872.1.
- In the last 5 years, Lexaria Bioscience's Other Gross PP&E Adjustments plummeted by 90918.18% in 2023 and then skyrocketed by 64480.53% in 2025.
- Lexaria Bioscience's Other Gross PP&E Adjustments (Quarter) stood at -$81656.0 in 2021, then plummeted by 803.67% to -$737903.0 in 2022, then soared by 78.78% to -$156565.0 in 2023, then rose by 18.23% to -$128025.0 in 2024, then skyrocketed by 644.81% to $697487.0 in 2025.
- Its Other Gross PP&E Adjustments was $697487.0 in Q4 2025, compared to $665510.0 in Q3 2025 and $658311.0 in Q2 2025.